NATEC Medical Ltd and US Endovascular Collaborate to Deliver a Brand New PTA Generation to the Peripheral US Market

Reduit, Mauritius - Peripheral Arterial Disease (PAD) is the narrowing or blockage of the vessels that carry blood from the heart to the organs. It is primarily caused by the build-up of fatty plaque in the arteries, which is called atherosclerosis. PAD can occur in any blood vessel, but it is more common in the legs than the arms.

Some facts:

• PAD affects 12 to 14% of the general population.
• PAD affects 20% of patients over the age of 75.
• Over 27 million people in the U.S. and Europe are estimated to have PAD.
• 220,000-240,000 amputations per year in the U.S./Europe
• 49% of those amputations had no diagnostic testing for PAD

NATEC Medical Ltd is pleased to announce an exclusive collaboration with US Endovascular to deliver on US market a brand new range of PTA balloon catheters. This new balloon technology is specifically engineered to address more complex peripheral artery disease (PAD), giving physicians the potential to treat more patients, with better outcomes, as well as potentially decrease the need for additional peripheral angioplasty devices. US Endovascular will launch 3 different PTA platforms:

• USE014” Rapid Exchange (Rx) and Over The Wire (OTW)
• USE018” OTW
• USE035” OTW

Source: NATEC Medical Ltd